Clinical Presentations And Surgical Outcomes Of Parotid Gland Tumors
Clinical Presentations And Surgical Outcomes Of Parotid Gland Tumors
DOI:
https://doi.org/10.70284/njirm.v6i5.957Keywords:
Facial nerve palsy, Parotid Gland, Parotidectomy, Pleomorphic AdenomaAbstract
Background & Objective: To assess Clinical Presentations and Surgical Outcomes of various parotid gland tumors which required Parotidectomy. Methodology: The present retrospective study was carried out at the Department of E.N.T. & Head Neck Surgery, Medical College Vadodara from January 2010 to December 2014 and included 34 patients who underwent parotidectomy. Data were collected regarding clinical presentations, benign versus malignant nature of the disease on FNAC reports, radiological findings, type of surgery instituted, complications encountered and histology reports of the surgical specimens and subjected to statistical analysis. Results: All patients had presented with a lump usually painless. Thirty (88%) patients had benign pathology while four (12%) had malignancies. Most common surgical procedure instituted was superficial parotidectomy, performed in 90% (n = 31). The most common complication was Sialocele (n=5; 15%) followed by facial nerve palsy (n= 2; 6%).The value of FNAC as a diagnostic tool was with 96.66% specificity and 75% sensitivity. Conclusion: Pleomorphic adenoma is most common benign pathology. Superficial parotidectomy is the most commonly offered surgical procedure. Parotid surgeries are safely performed with low morbidity and no mortality. [Jayman R NJIRM 2015; 6(5):6-10]
References
2. Takahama Junior A, Almeida OP, Kowalski LP. Parotidneoplasms: analysis of 600 patients attended at a singleinstitution. Braz J Otorhinolaryngol2009; 75:497-501.
3. Satko I, Stanko P, Longauerová I. Salivary gland tumourstreated in the stomatological clinics in Bratislava.CraniomaxillofacSurg2000; 28:56-61.
4. Al-Khateeb TH, Ababneh KT. Salivary glands tumours in NorthJordanians: a descriptive study. Oral Surg Oral Med OralPathol Oral RadiolEndod2007; 103:53-9.
5. Quer M, Pujol A, López M, GarcÃa J, Orús C, Sañudo JR.Parotidectomies in benign parotid tumours: "Sant Pau"surgical extension classification. ActaOtorrinolaringolEsp2010; 6:1-5.
6. Laccourreye H, Laccourreye O, Cauchois R, Jouffre V, MónardM, Brasnu D. Total conservative parotidectomy for primarybenign pleomorphic adenoma of the parotid gland: a 25-yearexperience with 229 patients.Laryngoscope 1994; 104: 1487-94.
7. Johnson JT, Ferlito A, Fagan JJ, Bradley PJ, Rinaldo A. Roleof limited parotidectomy in management of pleomorphicadenoma. J LaryngolOtol2007; 1:1-3.
8. Roh JL, Kim HS, Park CI.Randomized clinical trial comparingpartial parotidectomy versus superficial or total parotidectomy.Br J Surg2007; 94:1081-7.
9. Guntinas-Lichius O, Gabriel B, Klussmann JP. Risk of facial nerve palsy and severe Frey's syndrome after conservation parotidectomy for benign disease:analysis of 610 patients. Acta Oto-laryngologica 2006; 1104-9.
10. Auclair PL, Ellis GL, Gnepp DR, Wenig BN, Janey CG. Salivary gland neoplasms: general considerations. In: Ellis GL, Auclair PL, Gnepp DR, editors. Surgical pathology of salivary glands. Philadelphia: WB Saunders; 1991.p.135-64.
11. Kara MI, Goze F, Ezirganli S, Polat S, Muderris S, Elagoz S. Neoplasms of the salivary glands in a Turkish adult population. Med Oral Pathol Oral Cir Bucal 2010; 15:880-5.
12. Musani MA, Sohail Z, Zafar A, Malik S. Morphological pattern of parotid gland tumours. J Coll Physicians Surg Pak 2008; 18:274-7.
13. Malik KA. Parotid gland tumours: a six years experience. Pak J Surg 2007; 23:133-5.
14. Dorairajan N. Salivary gland tumours: a 10-year retrospective study of survival in relation to size, histopathological examination of the tumour, and nodal status. Int Surg 2004; 89:140-9.
15. Silas OA, Echejoh GO, Manasseh AN, Mandong BM. Patterns of malignant salivary glandtumours in Jos University Teaching Hospital (JUTH), Jos: a ten-year retrospective study. Niger J Med 2009; 18:282-5.
16. Amirlak B. Malignant parotid tumours. (serial online) Dec15, 2011: (03 screens) :(Cited Nov 03,2012). Available at: URL: emedicine.medscape.com/article/1289616-overview.
17. Li LJ, Li Y, Wen YM, Liu H, Zhao HW. Clinical analysis of salivary gland tumour cases in west china in past 50 years. Oral Oncol 2008; 44:187-92.
18. Subhashraj K. Salivary gland tumours: a single institution experience in India. Br J Oral Maxillofac Surg 2008; 46:635-8.
19. Vargas PA, Gerhaid R, Filho A, DeCastro IV VJ. Salivary gland tumours in Brazilian population: a retrospective study of 124 cases. Rev Hosp Clin Fac Med Sao Paulo 2002; 57:271-6.
20. Thakur J. Bilateral parotid tuberculosis. J Glob Infect Dis 2011; 3:296-9.
21. Awan MA, Ahmed Z. Diagnostic value of fine needle aspiration cytology in parotid tumours. J Pak Med Assoc 2004; 54: 617-20.
22. Hartimath B, Kudva A, Singh Rathore A. Role of fine-needle aspiration cytology in swellings of the parotid region. Indian J Surg 2011; 73:19-23.
23. Shashinder S, Tang IP, Velayutham P, Prepageran N, Gopala KG, Kuljit S, et al. A review of parotid tumours and their management: a ten-year-experience. Med J Malaysia 2009; 64:31-3.
24. Redaelli de Zinis LO. Management and prognostic factors of re-current pleomorphic adenoma of the parotid gland: personal experience and review of the literature. Eur Arch Otorhinolaryngol 2008; 265:447-52.
